TABLE 1.
Cytokine or chemokine |
Fold change in analyte level in CjS cells infected with: |
P value | Fold change in analyte level in EcS cells infected with: |
P value | Fold change in analyte level in EmS cells infected with: |
P value | |||
---|---|---|---|---|---|---|---|---|---|
Ba | E | Ba | E | Ba | E | ||||
Proinflammatory cytokines |
|||||||||
IL-1α | 2.45 ± 1.05 | 21.9 ± 16.24 | 0.0132 | 2.03 ± 1.17 | 9.4 ± 4.54 | 0.0137 | 4.77 ± 0.97 | 13.49 ± 6.51 | 0.0197 |
IL-1β | 2.58 ± 1.19 | 10.22 ± 5.66 | 0.0077 | 5.68 ± 4.57 | 69.39 ± 89.67 | 0.0570 | 5.65 ± 2.91 | 29.68 ± 8.1 | 0.0030 |
GM-CSF | 1 ± 0 | 78.4 ± 54.16 | 0.0030 | 16.68 ± 11.94 | 32.62 ± 34.67 | 0.6887 | 12.19 ± 12.66 | 15.12 ± 7.83 | 0.4779 |
IFN-γ | 0.4602 ± 0.7308 | 1.542 ± 2.037 | 0.7248 | 0.1339 ± 0.1313 | 1.696 ± 0.7026 | 0.004 | 3.113 ± 4.783 | 0.3289 ± 0.4524 | 0.4553 |
Regulatory T cells/Th2 cytokines |
|||||||||
IL-2 | 13.54 ± 10.23 | 12.73 ± 11.33 | 0.8005 | 12.67 ± 3.083 | 1 ± 0 | <0.0001 | 1.49 ± 1.77 | 0.71 ± 0.51 | 0.7713 |
TARC (CCL17) | 15.59 ± 7.76 | 3.12 ± 2.28 | 0.0407 | 1.09 ± 0.53 | 0.96 ± 0.17 | 0.3411 | 2.34 ± 0.68 | 1.15 ± 0.65 | 0.5980 |
Chemokines | |||||||||
IP-10 (CXCL10) | 1,036 ± 1,239 | 6.45 ± 3.21 | 0.0101 | 11.13 ± 10.93 | 0.68 ± 0.56 | 0.0509 | 59.17 ± 89.17 | 0.21 ± 0.09 | 0.0321 |
IL-12p70 | 5.78 ± 3.39 | 4.23 ± 0.28 | 0.6334 | 14.44 ± 3.02 | 7.79 ± 0.93 | 0.0122 | 10.25 ± 6.49 | 1.99 ± 0.71 | 0.0411 |
MIP-1β | 12.83 ± 5.68 | 1.82 ± 0.88 | 0.0099 | 13.57 ± 5.36 | 4.76 ± 3.79 | 0.1209 | 2.81 ± 1.89 | 1.64 ± 0.63 | 0.5105 |
IL-8 (CXCL8) | 13.25 ± 5.06 | 52.54 ± 26.65 | 0.0100 | 7.09 ± 8.07 | 8.08 ± 9.93 | 0.9855 | 13.36 ± 10.17 | 37.7 ± 28.29 | 0.1150 |
The cytokines and chemokines with strain-dependent differences are shown. Data are the same as in Fig. 4 and represent fold changes (with averages and standard deviations for four patients) from levels in uninfected cells. Underlining indicates a trend in the data; boldface italics indicate statistically significant P values.